Intravenous Access Using Infrared Laser
AccuV
Peripheral Intravenous Cannulation With Support of Infrared Laser Vein Viewing System in Obese Patients
1 other identifier
observational
100
1 country
1
Brief Summary
Peripheral venous access is a prerequisite for anesthesiological for surgical patients.It is often difficult to establish and potentially painful in obese patients (Body mass Index \> 35). AV300 uses near infrared laser light to improve visibility of peripheral veins and could help cannulating them. The aim of this study was to examine if use of Accuvein(®) AV300 vein viewer could facilitate venous cannulation in obese patients (surgical and obstetric).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 6, 2017
CompletedFirst Submitted
Initial submission to the registry
December 30, 2017
CompletedFirst Posted
Study publicly available on registry
June 14, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 4, 2019
CompletedJuly 8, 2019
July 1, 2019
1.1 years
December 30, 2017
July 4, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
success for second intravenous line using infra red
number of attempts
1 day
Secondary Outcomes (1)
time
1 day
Study Arms (1)
Obese
Patients need two intravenous access with infra red
Interventions
use of infra red for venous access for second intravenous access
Eligibility Criteria
Patients that need second intravenous access for surgery or obstetric
You may qualify if:
- \> 18 years
- surgery that need double intravenous perfusion
You may not qualify if:
- \< 18 years
- body mass index\< 35
- refusal
- minor surgery that need only one intravenous access
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Nimes
Nîmes, Gard, 30 000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
jean-yves Lefrant, MD,PhD
Centre Hospitalier Universitaire de Nīmes
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
December 30, 2017
First Posted
June 14, 2018
Study Start
November 6, 2017
Primary Completion
November 30, 2018
Study Completion
July 4, 2019
Last Updated
July 8, 2019
Record last verified: 2019-07
Data Sharing
- IPD Sharing
- Will not share